NCT03145532

Brief Summary

Hemiplegia occurs when the function of motor areas in the brain become impaired, predominantly unilaterally, during perinatal development. Children with hemiplegia show impairments in motor control of the affected side of the body. Impairments in use of the upper extremity are common, and lead to functional disability throughout the lifespan of a person with hemiplegia. Upper extremity impairments can severely affect a person's ability to carry out activities of daily living. The goal of this study at Blythedale Children's Hospital is to test the efficacy of transcranial direct current stimulation (tDCS) and robotic upper extremity therapy in improving upper extremity function in children with unilateral cerebral palsy. This study will test the hypothesis that physical rehabilitation, provided by repetitive arm movements guided by a robot, will improve upper extremity function in children with hemiplegia, and that this improvement can be enhanced by transcranial direct current stimulation of motor cortex immediately before robotic training.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 4, 2017

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 9, 2017

Completed
1 month until next milestone

Study Start

First participant enrolled

June 12, 2017

Completed
6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2023

Completed
Last Updated

January 10, 2022

Status Verified

January 1, 2022

Enrollment Period

6 years

First QC Date

May 4, 2017

Last Update Submit

January 5, 2022

Conditions

Outcome Measures

Primary Outcomes (3)

  • Change in Assisting Hand Assessment after intervention

    Assessment of how well children incorporate both hands into bimanual task performance, using an assessment tool called the "Assisting Hand Assessment"

    Within one week after the intervention ends

  • Change in Jebsen-Taylor Test of Hand Function after intervention

    Assessment of unimanual movement speed

    Within one week after the intervention ends

  • Change in Box and blocks test after intervention

    Assessment of unimanual function

    Within one week after the intervention ends

Study Arms (2)

Real tDCS plus robotic training

EXPERIMENTAL

Children will receive 20 min of real tDCS stimulation per session, followed by robotic training for 1 hr.

Other: tDCS plus robotic training

Sham tDCS plus robotic training

SHAM COMPARATOR

Children will receive 20 min of sham tDCS stimulation per session, followed by robotic training for 1 hr.

Other: tDCS plus robotic training

Interventions

Children will first receive 20 min of tDCS (real or sham, see Arms), then will receive 1 hr of upper limb robotic therapy in which the child will use their impaired arm and hand to move a joystick controlling a cursor to a set of targets on a video screen in front of the child.

Real tDCS plus robotic trainingSham tDCS plus robotic training

Eligibility Criteria

Age6 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Age 6-17
  • Participant and caregiver willing and able to provide informed consen/assent
  • Diagnosis of hemiplegia
  • Joint mobility: wrist extension, 20º, metacarpophalangeal and proximal interphalangeal joints 10º

You may not qualify if:

  • Cognitive deficits that impede understanding of study protocol
  • Current medical illness unrelated to CP
  • Visual problems (uncorrected by glasses/contact lenses)
  • High motor ability in affected arm Pre-intervention screening measures; Motor activity log, score \> 2.5 ( \> slight-to-moderate)
  • Severe spasticity Pre-intervention screening measures; Modified Ashworth test, score \> 3 ( \> moderate)
  • Lack of asymmetry in hand function
  • Orthopedic surgery in affected arm within 2 years
  • Dorsal root rhizotomy
  • Botulinum toxin therapy in either upper extremity during last 2 months, or planned during study period
  • Currently receiving intrathecal baclofen
  • Seizure beyond age 2, use of anti-seizure medication, history of epilepsy (in self or first degree relatives), brain surgery, cranial metal implants, structural brain lesion, devices that may be affected by TMS (pacemaker, medication pump, cochlear implant, implanted brain stimulator)
  • True positive response on the Transcranial Magnetic Stimulation Safety Screen
  • Current use of medications known to lower the seizure threshold
  • Previous episode of neurocardiogenic syncopy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kathleen Friel

Valhalla, New York, 10605, United States

Location

MeSH Terms

Conditions

Cerebral PalsyHemiplegia

Interventions

Transcranial Direct Current Stimulation

Condition Hierarchy (Ancestors)

Brain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesParalysisNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsConvulsive TherapyPsychiatric Somatic TherapiesBehavioral Disciplines and ActivitiesElectroshockPsychological Techniques

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Masking Details
tDCS will be blinded in that even children in the sham group will receive a low level of stimulation for a brief period.
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: Children will be randomized to receive either real or sham tDCS plus robotic training. Children in the sham group will be given the opportunity to repeat the protocol and receive real stimulation after they complete the sham protocol.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director, Cerebral Palsy Research

Study Record Dates

First Submitted

May 4, 2017

First Posted

May 9, 2017

Study Start

June 12, 2017

Primary Completion

June 1, 2023

Study Completion

June 1, 2023

Last Updated

January 10, 2022

Record last verified: 2022-01

Data Sharing

IPD Sharing
Will share

The investigators plan to share deidentified data in the NIH DASH (Data and Specimen Hub) database, sponsored by the National Institute of Child Health and Development (NICHD). Data will be archived to DASH upon study completion.

Locations